(Q33965308)

30 July 2017

title

Screening for hepatitis C virus in human immunodeficiency virus-infected individuals (English)

1 reference

30 July 2017

1 reference

1 reference

1

C L Thio

1 reference

30 July 2017

3

J Astemborski

1 reference

30 July 2017

4

D Vlahov

1 reference

30 July 2017

5

K E Nelson

1 reference

30 July 2017

6

D L Thomas

1 reference

30 July 2017

K R Nolt

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

Journal of Clinical Microbiology

30 July 2017

published in

1 reference

30 July 2017

volume

38

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

575-577

1 reference

Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=86151

Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=86151

Influence of HIV disease on serum anti-HCV antibody titers: a study of intravenous drug users

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=86151

Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=86151

The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=86151

Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=86151

Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=86151

Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=86151

Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV

29 October 2018

1 reference

12 December 2020

Specific syphilis serological tests may become negative in HIV infection

1 reference

12 December 2020

National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C

1 reference

12 December 2020

1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA)

1 reference

12 December 2020

Identifiers

PMC publication ID

86151

1 reference

30 July 2017

1 reference